//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दी
| 25 November, 2020, 05:03 AM IST | E-Paper
Search
+
ENG
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்

Ipca Laboratories Ltd.

  • NSE
  • BSE
Last Updated on 24 Nov, 2020, 03:58 PM IST
2210.45

Today's Change

12.80 (0.58%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

1,234,290

Open

2210.00

Prev. Close

2197.65

Day's Trend

Low
2135.00
High
2287.00
  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)78.89
  • BV/share (₹)288.17
  • 52Wk L/H1058.10/ 2460.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsCandle Pattern| Events| Recos| Updates| News
Buy Ipca Labs, target price Rs 1,900: Anand Rathi| Recos
Buy
Buy Ipca Laboratories, target Rs 915: Nomura| Recos
Buy
Outperform Ipca Laboratories, target Rs 920: IDFC Securities| Recos
Outperform
Buy Ipca Laboratories, target Rs 720: YES Securities| Recos
Buy
Ipca Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Ipca Laboratories Ltd.Corporate Action-Board approves Dividend| Announcement
Ipca Laboratories Ltd.Standalone And Consolidated Unaudited Financial Results Along With Limited Review Report Of The Companys Statutory Audit...| Announcement
Ipca Laboratories Ltd.Standalone And Consolidated Unaudited Financial Results Along With Limited Review Report Of The Companys Statutory Audit...| Announcement
Ipca Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Ipca Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Ipca Laboratories Ltd.Fixes Record Date for Interim Dividend| Announcement
Ipca Laboratories Ltd.Announcement under Regulation 30 (LODR)-Dividend Updates| Announcement
Ipca Laboratories Ltd.Corporate Action-Board to consider Dividend| Announcement
Ipca Laboratories Ltd.Board Meeting Intimation for To Consider And Take On Record The Unaudited Financial Results For The 2Nd Quarter And Half...| Announcement
Ipca Laboratories Ltd.Shareholding for the Period Ended September 30, 2020| Announcement
Ipca Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended September 2020| Announcement
Ipca Laboratories Ltd.Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.| Announcement
Ipca Laboratories Ltd.Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Req...| Announcement
Ipca Laboratories Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
Ipca Laboratories Ltd.Closure of Trading Window| Announcement
Ipca Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Ipca Laboratories Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
Ipca Laboratories Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
Ipca Laboratories Ltd.Shareholder Meeting / Postal Ballot-Outcome of AGM| Announcement
Pharma euphoria may reverse soon, and how!| News
Ipca Labs Q1 profit at Rs 65 crore| News

Ipca Laboratories Ltd. Share Price Updates

Ipca Laboratories Ltd. share price up by 0.58% from its previous close of Rs 2197.65. Ipca Laboratories Ltd. stock last traded price is 2210.45
Ipca Laboratories Ltd. Share Price
Value
Today/Current/Last
2210.45
Previous Day
2197.65
What's your view on Ipca Laboratories for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Ipca Laboratories Ltd.

Ipca Laboratories Ltd.
Quarterly Results

Figures in Rs. Cr
Sep 2020 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
1,361.10
-11.29
6.01
0.04
8553.13
Other Operating Income
0.00
0.00
0.00
-0.94
105.53
Operating Profit
360.19
-38.78
35.48
-17.59
3074.97
Other Income
15.45
27.79
4.39
-31.88
255.78
EBITDA
375.64
-37.44
33.84
-17.59
3074.97
Interest
2.31
-15.69
-45.39
0.00
80.63
Depreciation
52.12
2.14
5.02
0.00
498.60
Tax
52.59
-47.35
64.91
-88.40
387.33
Net Profit
267.07
-40.14
38.33
-33.67
1812.79
EPS (₹)
21.08
-40.18
37.60
-11.31
46.40

Ipca Laboratories Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
2210.45
0.58
5.14
1.61
9.92
99.88
315.77
187.76
480.50
0.14
-1.38
-1.02
-1.59
39.66
-19.01
-50.23
521.35
-0.60
-1.25
4.42
-4.93
25.76
-17.96
0.00
2775.65
0.55
3.65
6.71
-0.87
33.52
39.63
0.00
289.70
-0.24
3.67
-13.66
21.76
332.19
169.36
0.00
1527.75
0.03
-1.57
-4.87
-5.17
52.70
14.94
13.70
995.55
0.24
3.45
2.24
-1.26
82.54
93.12
46.86
729.10
-0.33
5.57
-6.07
-14.04
40.96
14.65
74.32
913.15
0.19
0.19
-0.75
7.27
64.18
-1.20
77.06
573.60
1.83
-0.61
7.32
20.14
75.90
117.70
214.47
1145.65
0.89
1.55
15.18
-2.34
38.77
151.11
348.92
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Ipca Laboratories Ltd Risk Return Comparison

with peersNew

Ipca Laboratories Ltd
Financial Comparison

with peers
Management Efficiency
Ipca Laboratories Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
16.76
7.20
-97.73
37.52
Return on Assets (%)
12.25
4.43
-51.80
37.98
Return on capital Employed (%)
11.99
6.12
-86.49
33.55
Fixed Assets Turnover (x)
1.23
0.48
-36.70
3.82
Profitability and Growth
Gross Profit Margin (%)
14.97
-3.40
-831.69
43.32
Operating Profit Margin(%)
19.50
3.03
-802.77
46.18
Net Profit margin (%)
13.04
-8.87
-653.62
38.01
Financial Strength
Liquidity
Quick Ratio (x)
1.19
2.00
0.08
37.52
Current Ratio (x)
2.29
2.76
0.21
37.52
Cash ratio (x)
0.15
0.24
0.00
2.43
Solvency
Debt Equity Ratio (x)
0.03
0.24
0.00
3.08
Coverage Ratios
Cash flows to long term debt (x)
0.50
2.78
0.00
24.88
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Ipca Laboratories Ltd Share Holding as on 30-09-2020

CategoryNo. of sharesPercentage
Promoters58,216,23646.07
ForeignInstitutions15,673,79512.40
NBanksMutualFunds29,729,18723.53
CentralGovt355,5770.28
Others3,637,9592.88
GeneralPublic12,272,9069.71
FinancialInstitutions6,466,4495.12

MF Ownership Of Ipca Laboratories Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
HDFC Mid-Cap Opportunities Direct-G
Portfolio as on 31-10-2020
Equity: Mid Cap
3728500
0.00%
3.95%
862.44
DSP Midcap Direct-G
Portfolio as on 31-10-2020
Equity: Mid Cap
2000066
0.00%
5.5%
462.64
Axis Midcap Direct-G
Portfolio as on 31-10-2020
Equity: Mid Cap
1655400
0.00%
5.51%
382.91
DSP Small Cap Direct-G
Portfolio as on 31-10-2020
Equity: Small Cap
1361138
-11.22%
5.92%
314.84
L&T Midcap Direct-G
Portfolio as on 31-10-2020
Equity: Mid Cap
1037300
0.00%
4.15%
239.94

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes »

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 27929.50 Crore) operating in Pharmaceuticals sector.

Ipca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 4302.75 Crore to Sales Value (98.51 % of Total Sales), Export Incentives which contributed Rs 44.45 Crore to Sales Value (1.01 % of Total Sales), Other Operating Revenue which contributed Rs 15.69 Crore to Sales Value (0.35 % of Total Sales) and Sale of services which contributed Rs 4.54 Crore to Sales Value (0.10 % of Total Sales)for the year ending 31-Mar-2020.

For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 1361.10 Crore, down -11.29 % from last quarter Sales of Rs 1534.40 Crore and up 6.01 % from last year same quarter Sales of Rs 1283.90 Crore Company has reported net profit after tax of Rs 268.62 Crore in latest quarter.

The company’s top management includes Dr.(Mrs.)Manisha Premnath, Mr.Ajit Kumar Jain, Mr.Anand T Kusre, Mr.Dev Parkash Yadava, Mr.Kamal Kishore Seth, Mr.Pranay Godha, Mr.Prashant Godha, Mr.Premchand Godha. Company has G M Kapadia & Co as its auditors. As on 30-09-2020, the company has a total of 126,352,109 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

The Economic Times

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors